Atopic Dermatitis (Eczema)

18-65 years of age | Male or Female

To assess the safety and effectiveness of an investigational topical (on the skin) therapy versus placebo in patients with atopic dermatitis.

Eligibility

• Diagnosis of atopic dermatitis that currently affects at least 3% body surface area
• Willing to stop use of any other eczema treatments for the duration of the study

Trial Duration

6 visits over ~10

Compensation

Compensation up to $100 for each completed office visit.